Cargando…
Cilostazol effectiveness in reducing drug-coated stent restenosis in the superficial femoral artery: The ZERO study
PURPOSE: Drug-eluting stents (DESs) play an important role in endovascular therapy (EVT) for femoropopliteal (FP) lesions. Cilostazol improves patency after bare-metal nitinol stent (BNS) implantation for femoropopliteal lesions. This study aimed to establish whether cilostazol is effective in impro...
Autores principales: | Miura, Takashi, Miyashita, Yusuke, Hozawa, Koji, Doijiri, Tatsuki, Kato, Tamon, Hayakawa, Naoki, Hashizume, Naoto, Nakano, Masatsugu, Ikeda, Uichi, Kuwahara, Koichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262206/ https://www.ncbi.nlm.nih.gov/pubmed/35797395 http://dx.doi.org/10.1371/journal.pone.0270992 |
Ejemplares similares
-
Intensive exercise therapy for restenosis after superficial femoral artery stenting: the REASON randomized clinical trial
por: Kato, Tamon, et al.
Publicado: (2022) -
Drug-coated balloon in superficial femoral artery in-stent restenosis
por: Gerardi, Donato, et al.
Publicado: (2018) -
Directional Atherectomy for Treating In-Stent Restenosis of the Superficial Femoral Artery
por: Cho, Sungsin, et al.
Publicado: (2020) -
In-stent restenosis of superficial femoral artery: use all arrows in the quiver
por: Vadalà, Giuseppe, et al.
Publicado: (2022) -
Prognostic Factors for Restenosis of Superficial Femoral Artery after Endovascular Treatment
por: Boc, Vinko, et al.
Publicado: (2023)